Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
44.56
-0.60 (-1.33%)
Official Closing Price
Updated: 4:10 PM EDT, Sep 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,793,306
Open
45.00
Bid (Size)
44.61 (2,500)
Ask (Size)
44.70 (100)
Prev. Close
45.16
Today's Range
44.52 - 45.40
52wk Range
35.12 - 64.16
Shares Outstanding
N/A
Dividend Yield
5.72%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Is Novo Nordisk Stock Still Too Cheap for Investors to Ignore?
↗
September 08, 2026
Shares of Novo Nordisk are trading 66% below their 2024 high, but is that enough to call them cheap? Maybe.
Via
The Motley Fool
Topics
Intellectual Property
3 of the Best Growth Stocks to Buy for Less Than $100 Right Now
↗
September 08, 2026
Netflix, Uber, and Novo Nordisk are all excellent, undervalued stocks to buy today.
Via
The Motley Fool
Performance
YTD
-14.9%
-14.9%
1 Month
-6.6%
-6.6%
3 Month
+5.6%
+5.6%
6 Month
+15.1%
+15.1%
1 Year
-17.9%
-17.9%
More News
Read More
Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?
↗
September 07, 2026
Via
The Motley Fool
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case.
↗
September 05, 2026
Via
The Motley Fool
2 Stocks Down 8% or More That Are Screaming Buys Right Now
↗
September 04, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Should Eli Lilly Investors Be Worried About a Threat From Amylyx?
↗
August 30, 2026
Via
The Motley Fool
Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?
↗
August 29, 2026
Via
The Motley Fool
Billionaire Stanley Druckenmiller Is Quietly Loading Up on Healthcare Stocks -- Here's What His New Positions Reveal
↗
August 26, 2026
Via
The Motley Fool
Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can
↗
August 23, 2026
Via
The Motley Fool
2 Biotech Stocks Shaping Up for Major Breakouts
↗
August 22, 2026
Via
MarketBeat
Topics
ETFs
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
August 18, 2026
From
Equity Insider
Via
GlobeNewswire
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now
↗
August 18, 2026
Via
The Motley Fool
GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk)
↗
August 14, 2026
Via
The Motley Fool
Topics
Intellectual Property
Eli Lilly Just Scored Europe's First Weight Loss Pill Approval -- and the Growth Story Keeps Getting Bigger
↗
August 14, 2026
Via
The Motley Fool
Eli Lilly's GLP-1 Pricing Problem Is Actually a Growth Opportunity
↗
August 13, 2026
Via
The Motley Fool
Is Novo Nordisk's Wegovy-Fueled Rebound Evaporating?
↗
August 13, 2026
Via
The Motley Fool
Hims & Hers’ Revenue Beat Came With a Profitability Problem
↗
August 12, 2026
Via
MarketBeat
Topics
Earnings
Lawsuit
Novo Nordisk Stock: Buy or Sell?
↗
August 11, 2026
Via
The Motley Fool
Better Buy: Eli Lilly vs. Novo Nordisk
↗
August 11, 2026
Via
The Motley Fool
Why Eli Lilly Topped the Market Today
↗
August 10, 2026
Via
The Motley Fool
Novo Nordisk A/S Q2 Earnings Call Highlights
↗
August 08, 2026
Via
MarketBeat
Topics
Earnings
Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem
↗
August 07, 2026
Via
The Motley Fool
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound
↗
August 07, 2026
Via
The Motley Fool
Why Is Everyone Talking About Novo Nordisk?
↗
August 06, 2026
Via
The Motley Fool
The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic
↗
August 05, 2026
Via
MarketBeat
Topics
Lawsuit
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 44.56
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 09/09/26 04:10 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.